October 12, 2016
(from left) Mr Iwasaki, Mr Israeli, Mr Matsumori A Takeda-Teva joint venture made a new start on October 1 under the new name of Teva Takeda Pharma. Embracing what it dubs an “off-patent drug (OPD)” strategy, the JV is looking...read more